Sophiris Bio
(SPHS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,941 | 16,286 | 16,087 | 16,486 | 6,824 |
| Marketable Securities | 4,587 | 5,767 | 9,757 | 12,027 | 17,205 |
| Receivables | N/A | 13 | N/A | 62 | 69 |
| TOTAL | $19,583 | $23,075 | $26,856 | $29,693 | $25,046 |
| Non-Current Assets | |||||
| PPE Net | 3 | 3 | 2 | 3 | 2 |
| Other Non-Current Assets | 0 | 19 | 19 | 0 | 0 |
| TOTAL | $3 | $22 | $21 | $3 | $2 |
| Total Assets | $19,586 | $23,097 | $26,877 | $29,696 | $25,048 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,271 | 1,132 | 832 | 737 | 506 |
| Accrued Expenses | 2,662 | 1,824 | 1,499 | 1,484 | 1,154 |
| TOTAL | $5,481 | $3,914 | $2,703 | $2,221 | $1,660 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,362 | 5,900 | 6,435 | 6,756 | N/A |
| Other Non-Current Liabilities | 10,099 | 8,733 | 10,089 | 9,491 | 10,162 |
| TOTAL | $15,461 | $14,633 | $16,524 | $16,247 | $10,162 |
| Total Liabilities | $20,942 | $18,547 | $19,227 | $18,468 | $11,822 |
| Shareholders' Equity | |||||
| Common Shares | 131,247 | 131,247 | 131,247 | 131,246 | 131,246 |
| Retained earnings | -158,974 | -152,876 | -149,548 | -145,584 | -142,929 |
| Other shareholders' equity | 97 | 94 | 97 | 96 | 85 |
| TOTAL | $-1,356 | $4,550 | $7,650 | $11,228 | $13,226 |
| Total Liabilities And Equity | $19,586 | $23,097 | $26,877 | $29,696 | $25,048 |